Working… Menu

Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02101853
Recruitment Status : Active, not recruiting
First Posted : April 2, 2014
Last Update Posted : April 5, 2021
Information provided by (Responsible Party):
National Cancer Institute (NCI)